United Asset Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
United Asset Strategies's BMY Position: Q1 2020 in Review
United Asset Strategies sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 3,803 shares — an estimated $244K sold.
United Asset Strategies first reported a position in BMY in Q3 2014 and held it in 19 quarters. The position peaked at $356K in Q4 2015. 2,148 funds tracked by Wall St. Rank hold BMY as of Q1 2020.
- United Asset Strategies reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
- United Asset Strategies sold 3,803 Bristol-Myers Squibb shares in Q1 2020, an estimated $244K.
- United Asset Strategies first reported a position in Bristol-Myers Squibb in Q3 2014 and held it in 19 quarters.
- United Asset Strategies's Bristol-Myers Squibb position peaked at $356K in Q4 2015.
- 2,148 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.
Based on United Asset Strategies's 13F filing for Q1 2020, filed 8 May 2020.